BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Breast
,
Biofuel
,
Ciprofibrate
,
rs3825942
,
SLC12A1
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SARS- CoV- M protein
Summary
General Info
Curated Studies
Most Correlated Studies
Infection of kidney cell lines with mutant and wildtype SARS-CoV
Umbilical vein endothelial cells stimulated with plasma of SARS-CoV-2+ patients
Lungs of Casp11 or Gsdmd knockout mice intranasally infected with SARS-CoV-2 MA10 strain
Peripheral blood mononuclear cells and Bronchoalveolar lavage cells from macaques with SARS-CoV-2
Lung adenocarcinoma Calu-3 cells infected with SARS-CoV-2 on treatment with 2-D08 or TOLLIP siRNA
Explore Curated Studies Results
Literature
Most Relevant Literature
Disruption of the Golgi Apparatus and Contribution of the Endoplasmic Reticulum to the SARS-CoV-2 Re…
Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2*.
An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: …
Construction of SARS-CoV-2 virus-like particles in plant.
The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Aotus…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Mat…
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY AD…
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ